Christopher J. Kane, MD, FACS, presented “Panel Discussion on Integration of Stakeholders in Healthcare: Academic Urology” during the 30th Annual International Prostate Cancer Update on January 23rd, 2020 in Beaver Creek, Colorado.
How to cite: Kane, Christopher J. “Panel Discussion on Integration of Stakeholders in Healthcare: Academic Urology” January 23rd, 2020. Accessed Jul 2024. https://grandroundsinurology.com/panel-discussion-on-integration-of-stakeholders-in-healthcare-academic-urology/
Panel Discussion on Integration of Stakeholders in Healthcare: Academic Urology – Summary:
Christopher J. Kane, MD, FACS, Dean of Clinical Affairs at the University of California San Diego School of Medicine, discusses the role of academic institutions in supporting the wider urology community, using USCD as an example. He notes that the UC medical system is the 4th largest provider of healthcare in California and UCSD is the 8th producer of scientific output in life sciences of any institution globally, therefore contributing greatly to the medical field as a whole. USCD Urology provides numerous specific benefits to the greater urology community, including practitioners in LUGPAs and integrated practice systems. These benefits include subspecialty coordinated care, CME opportunities, principled defense and professional support, and a clinically integrated network, among others.
About The 30th Annual International Prostate Cancer Update:
The International Prostate Cancer Update (IPCU), founded in 1990, is a multi-day CME conference focused on prostate cancer treatment updates with expert, international faculty. It is led by expert physicians and is designed for urologists, medical oncologists, radiation oncologists, and other healthcare professionals involved in the diagnosis and treatment of prostate cancer. Dr. Kane delivered this educational activity during the 30th iteration of the meeting in January 2020.
For further educational activities from this conference, visit our collection page.
ABOUT THE AUTHOR
Christopher J. Kane, MD, FACS, is Dean of Clinical Affairs at the University of California (UC), San Diego School of Medicine. He is also Chief Executive Officer (CEO) of UC San Diego Health Physician Group and Professor of Urology at UC San Diego Health. Dr. Kane is on the Executive Governing Board of UC San Diego Health Sciences and the Executive Committee of UC San Diego’s Clinical Integration Network. In addition, he is the president of the Western Section American Urological Association (AUA) and trustee of the American Board of Urology (ABU).
Dr. Kane is an internationally recognized expert in prostate cancer and kidney cancer epidemiology, risk stratification, and outcomes after treatment. He completed his urology residency at Oakland Naval Hospital and UC San Francisco. Dr. Kane earned his medical degree at Uniformed Services University in Bethesda, Maryland, and his BS degree in mechanical engineering at UC Davis. From 2009 to 2016, he was Co-Chair of the Renal Cell Carcinoma Advisory Task Force, National Cancer Institute. Dr. Kane is on the AUA guidelines in prostate cancer committee and was elected to the American Association of Genitourinary Surgeons (AAGUS) in 2014. In 2017 Dr. Kane was elected to the Clinical Society of Genitourinary Surgeons (GSGUS). He was selected as a “Top Doctor” in San Diego in 2008-2022. In 2010, he was selected as one of two Physician Healthcare Champions in San Diego by the San Diego Business Journal and was awarded the Distinguished Engineering Alumni Medal by UC Davis in 2011. Dr. Kane is a retired Navy Captain and a decorated veteran of Desert Storm. He has authored over 370 publications and book chapters, primarily on prostate cancer risk factors and outcomes, prostate cancer surgery, and minimally invasive surgery for prostate and kidney cancer.
